☰

Drew R. Jones, Ph.D. - Publications

Affiliations: 
2011 Biochemistry and Molecular Biology University of Arkansas for Medical Sciences, United States 
Area:
Biochemistry, Pharmacology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Curran DM, Grote A, Nursimulu N, Geber A, Voronin D, Jones DR, Ghedin E, Parkinson J. Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets. Elife. 9. PMID 32779567 DOI: 10.7554/Elife.51850  0.388
2020 Wang X, Cho JH, Poudel S, Li Y, Jones DR, Shaw TI, Tan H, Xie B, Peng J. JUMPm: A Tool for Large-Scale Identification of Metabolites in Untargeted Metabolomics. Metabolites. 10. PMID 32408578 DOI: 10.3390/Metabo10050190  0.357
2020 Parker SJ, Amendola CR, Hollinshead KER, Yu Q, Yamamoto K, Encarnacion-Rosado J, Rose RE, LaRue MM, Sohn ASW, Biancur DE, Paulo JA, Gygi SP, Jones DR, Wang H, Philips MR, et al. Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Cancer Discovery. PMID 32341021 DOI: 10.1158/2159-8290.Cd-19-0959  0.355
2019 Curran DM, Grote A, Nursimulu N, Geber A, Voronin D, Jones DR, Ghedin E, Parkinson J. Author response: Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets Elife. DOI: 10.7554/Elife.51850.Sa2  0.364
2018 Xie B, Wang Y, Jones DR, Dey KK, Wang X, Li Y, Cho JH, Shaw TI, Tan H, Peng J. Isotope Labeling-assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling. Analytical Chemistry. PMID 29883117 DOI: 10.1021/Acs.Analchem.8B01591  0.329
2018 Wang X, Jones DR, Shaw TI, Cho JH, Wang Y, Tan H, Xie B, Zhou S, Li Y, Peng J. Target-decoy Based False Discovery Rate Estimation for Large-scale Metabolite Identification. Journal of Proteome Research. PMID 29790753 DOI: 10.1021/Acs.Jproteome.8B00019  0.341
2018 Kim SY, Jones DR, Kang JY, Yun CH, Miller GP. Regioselectivity Significantly Impacts Microsomal Glucuronidation Efficiency of R/S-6, 7-, and 8-Hydroxywarfarin. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25. PMID 29543105 DOI: 10.1080/00498254.2018.1451668  0.584
2014 Jones DR, Wu Z, Chauhan D, Anderson KC, Peng J. A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myeloma. Analytical Chemistry. 86: 3667-75. PMID 24611431 DOI: 10.1021/Ac500476A  0.341
2013 Jones DR, Boysen G, Miller GP. Erratum to “Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma” [J. Chromatogr. B 879 (2011) 1056–1062] Journal of Chromatography B. 919: 61. DOI: 10.1016/J.Jchromb.2013.01.007  0.499
2012 Kim SY, Kang JY, Hartman JH, Park SH, Jones DR, Yun CH, Boysen G, Miller GP. Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins. Drug Metabolism Letters. 6: 157-64. PMID 23331088 DOI: 10.2174/1872312811206030002  0.614
2011 Jones DR, Miller GP. Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know. Expert Opinion On Drug Metabolism & Toxicology. 7: 857-74. PMID 21480820 DOI: 10.1517/17425255.2011.576247  0.615
2011 Jones DR, Boysen G, Miller GP. Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 879: 1056-62. PMID 21470921 DOI: 10.1016/J.Jchromb.2011.03.022  0.608
2010 Jones DR, Kim SY, Boysen G, Yun CH, Miller GP. Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. Drug Metabolism Letters. 4: 213-9. PMID 20615193 DOI: 10.2174/187231210792928242  0.616
2010 Jones DR, Kim SY, Guderyon M, Yun CH, Moran JH, Miller GP. Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. Chemical Research in Toxicology. 23: 939-45. PMID 20429590 DOI: 10.1021/Tx1000283  0.602
2010 Jones DR, Moran JH, Miller GP. Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism. Drug Metabolism Reviews. 42: 55-61. PMID 19788348 DOI: 10.3109/03602530903209395  0.612
2009 Miller GP, Jones DR, Sullivan SZ, Mazur A, Owen SN, Mitchell NC, Radominska-Pandya A, Moran JH. Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans. Chemical Research in Toxicology. 22: 1239-45. PMID 19408964 DOI: 10.1021/Tx900031Z  0.616
Show low-probability matches.